Dr Robert Chu, CEO of Embleema Health announced a partnership with WHISE CEO Dr. Prof. Vahan Simonyan, former R&D Director of Bioinformatics at the U.S. Food and Drug Administration (FDA).
- Embleema implements patient-driven healthcare blockchain network for secure sharing of medical records, and it provides HL7 FHIR based medical record standardizatio and aggregation engine to accumulate and dissiminate Real World Evidence data.
- WHISE implements distributed secure ecosystems for large scale data storage and Biocompute driven computations, massive scale data analytics capacity and compatibility with FDA compliant analytics for genomics, proteomics, etc.
- Together these two platforms are now building hardware and software integrated layers for seamless patient level data exchange protocols that are compliant to HIPAA and GDPR by design.
- WHISE and Embleema integrate their consent and permission frameworks through blockchain smart contracts to provide utmost level of immutable provenance compliant with regulatory requirement of CFR 21 part 11 for evidence synthesis and sustainability.
